Bank of America Upgrades Mettler-Toledo International (NYSE:MTD) to “Buy”

Mettler-Toledo International (NYSE:MTD) was upgraded by equities research analysts at Bank of America from a “neutral” rating to a “buy” rating in a research report issued on Monday, MarketBeat.com reports. The firm currently has a $1,600.00 price target on the medical instruments supplier’s stock. Bank of America‘s price target points to a potential upside of 15.35% from the company’s previous close.

A number of other research analysts have also recently commented on MTD. Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Wells Fargo & Company lifted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Stifel Nicolaus upped their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 8th. Finally, Barclays boosted their price target on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a research note on Monday, November 10th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus price target of $1,441.67.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,387.07 on Monday. Mettler-Toledo International has a 12 month low of $946.69 and a 12 month high of $1,525.17. The stock’s 50-day moving average is $1,405.14 and its two-hundred day moving average is $1,297.26. The stock has a market cap of $28.34 billion, a PE ratio of 34.59, a P/E/G ratio of 4.56 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating the consensus estimate of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company’s revenue was up 7.9% on a year-over-year basis. During the same period last year, the business posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, research analysts anticipate that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Elisha W. Finney sold 474 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total value of $679,512.18. Following the sale, the director owned 311 shares in the company, valued at approximately $445,840.27. This represents a 60.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 236 shares of Mettler-Toledo International stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the completion of the transaction, the insider owned 159 shares of the company’s stock, valued at $225,554.22. This trade represents a 59.75% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 19,565 shares of company stock worth $28,683,737. Company insiders own 0.77% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors have recently made changes to their positions in the company. Public Sector Pension Investment Board boosted its holdings in Mettler-Toledo International by 7.5% in the first quarter. Public Sector Pension Investment Board now owns 2,854 shares of the medical instruments supplier’s stock worth $3,370,000 after purchasing an additional 200 shares during the period. Horizon Investments LLC lifted its position in shares of Mettler-Toledo International by 4.2% in the 1st quarter. Horizon Investments LLC now owns 299 shares of the medical instruments supplier’s stock worth $353,000 after buying an additional 12 shares during the last quarter. Ethic Inc. lifted its position in shares of Mettler-Toledo International by 1.6% in the 1st quarter. Ethic Inc. now owns 2,440 shares of the medical instruments supplier’s stock worth $2,822,000 after buying an additional 39 shares during the last quarter. Corient IA LLC acquired a new position in shares of Mettler-Toledo International in the 1st quarter valued at about $295,000. Finally, Algert Global LLC grew its position in shares of Mettler-Toledo International by 17.8% during the 1st quarter. Algert Global LLC now owns 4,255 shares of the medical instruments supplier’s stock valued at $5,025,000 after buying an additional 644 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.